Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
Saved in:
| Title: | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. |
|---|---|
| Authors: | Lima JJ; Center for Pharmacogenomics and Translational Research, Nemours Children's Health, Jacksonville, Florida, USA., Thomas CD; Department of Pharmacotherapy and Translational Research, and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Barbarino J; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Desta Z; Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Van Driest SL; Departments of Pediatrics and Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., El Rouby N; Department of Pharmacotherapy and Translational Research, and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA.; Division of Pharmacy Practice & Administrative Sciences, University of Cincinnati James Winkle College of Pharmacy, Cincinnati, Ohio, USA., Johnson JA; Department of Pharmacotherapy and Translational Research, and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Cavallari LH; Department of Pharmacotherapy and Translational Research, and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Shakhnovich V; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City and University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.; Division of Gastroenterology, Hepatology, and Nutrition, Children's Mercy Kansas City, Kansas City, Missouri, USA.; Center for Children's Healthy Lifestyles & Nutrition, Kansas City, Missouri, USA., Thacker DL; Department of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.; Translational Software, Bellevue, Washington, USA., Scott SA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Sema4, Stamford, Connecticut, USA., Schwab M; Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; Department of Clinical Pharmacology, University Hospital, Tuebingen, Germany.; Department of Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany., Uppugunduri CRS; CANSEARCH Research Laboratory, Department of Pediatrics, Gynecology, and Obstetrics, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Oncology-Hematology Unit, Department of Pediatrics, Gynecology, and Obstetrics, Geneva University Hospital, Geneva, Switzerland., Formea CM; Department of Pharmacy Services and Intermountain Precision Genomics, Intermountain Healthcare, Salt Lake City, Utah, USA., Franciosi JP; Division of Gastroenterology, Hepatology, and Nutrition, Nemours Children's Hospital, Orlando, Florida, USA.; Department of Pediatrics, University of Central Florida College of Medicine, Orlando, Florida, USA., Sangkuhl K; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Gaedigk A; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City and University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA., Klein TE; Department of Biomedical Data Science, Stanford University, Stanford, California, USA., Gammal RS; Department of Pharmacy Practice, MCPHS University School of Pharmacy, Boston, Massachusetts, USA.; Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA., Furuta T; Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Jun; Vol. 109 (6), pp. 1417-1423. Date of Electronic Publication: 2020 Sep 20. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Practice Guideline |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
